DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cabazitaxel
Cabazitaxel
Re-Visiting Hypersensitivity Reactions to Taxanes: a Comprehensive Review
Jevtana® (Cabazitaxel)
BC Cancer Benefit Drug List September 2021
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: from Discovery to Implementation
Psma-1-Doxorubicin Conjugates for Targeted Therapy of Prostate Cancer
Jevtana, INN-Cabazitaxel
Chapter 10: Urological Cancer
Human Medicines Highlights Newsletter’ and Then Click on ‘Subscribe to This Feed’
Establishing a Preclinical Multidisciplinary Board for Brain Tumors Birgit V
Jevtana (Cabazitaxel)
Pharmacology Review(S) Memorandum
Cancer Nanobiotechnolgy
Clinical Pharmacology and Biopharmaceutics Review(S)
Chemotherapeutic Drugs in Lebanese Surface Waters: Estimation of Population Exposure and Identifcation of High-Risk Drugs
Provincial Systemic Therapy Program
Cancer Drug Costs for a Month of Treatment at Initial Food
Utility of Prophylactic Antibiotics for Preventing Febrile Neutropenia
Biweekly Cabazitaxel Is a Safe Treatment Option for Metastatic
Top View
Preclinical Antitumor Activity of Cabazitaxel, a Semi
Bc Cancer Chemotherapy Preparation and Stability
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
Prostate Cancer Resistance to Cabazitaxel Chemotherapy
Imbruvica Demonstrates 88% Response Rate in Studies Of
Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy
Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer
Emerging Drugs for Prostate Cancer
Separately Chargeable Drugs List
Cabazitaxel Jevtana
Chemotherapy in Patients with Metastatic Prostate Cancer
Jevtana, INN-Cabazitaxel
Mechanisms of Taxane Resistance
EMA/PDCO Summary Report on the Review of the List of Granted Class Waivers
Emetogenic Potential of Antineoplastic Agents
A Treatment Option in Recurrent Platinum-Resistant Ovarian Cancer
Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors
Reimbursement Criteria for Frequently Requested Drugs
Adult Antiemetic Management of Chemotherapy-Induced Nausea
Policy Drug(S) Brief Description of Policy Change Add Inclusion Criteria: NOTE: the Preferred Dose of Jevtana for NCH Policy Is 20 Mg/M2, IV, Every 3 Weeks
Emetogenic Potential of Antineoplastic Agents
Immunotherapy and Cancer – Making the Past Prologue
Cabazitaxel: Drug Information
ABCC4 Decreases Docetaxel and Not Cabazitaxel Efficacy in Prostate Cancer Cells in Vitro
Current Taxane Formulations and Emerging Cabazitaxel Delivery Systems
DRUG NAME: Cabazitaxel
Acute Mucositis and Gastrointestinal Toxicity Caused by Radiotherapy Or Systemic Anti-Cancer Treatment 2019
Practical Guide to the Use of Chemotherapy in Castration Resistant Prostate Cancer Daniel P
Guidelines for the Use of Anti-Emetics with Chemotherapy
Outcome of Combination Chemotherapy with Docetaxel
Muscle Invasive Bladder Cancer Patients: a Systematic Literature Review
Emetic Risk of Single Intravenous Antineoplastic Agents in Adults
Drug Repurposing in Malignant Pleural Mesothelioma: a Breath of Fresh Air?
Original Article Cabazitaxel, a Novel Chemotherapeutic Alternative for Drug-Resistant Hepatocellular Carcinoma
[2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
2020 Table of Drugs
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug Administration Approval
Year of FDA Monthly Cost Approval
Antiproliferative Mechanism of Action of the Novel Taxane Cabazitaxel As Compared with the Parent Compound Docetaxel in MCF7 Breast Cancer Cells
Jevtana® (Cabazitaxel)
Single Technology Appraisal Cabazitaxel for the Second Line
Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer
Cabazitaxel in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: Phase II UNICANCER Trial ORL03
Do Not Tube List
Open Full Page
Full Text (PDF)
HUMAN MEDICINES HIGHLIGHTS Key Information for Patients, Consumers and Healthcare Professionals
Cabazitaxel Teva, INN-Cabazitaxel
Microneedles Drug Delivery Systems for Treatment of Cancer: a Recent Update
Thames Valley Chemotherapy Regimens
List Item Cabazitaxel Accord